China Resources Pharmaceutical Group Limited (HKG:3320)
4.760
-0.060 (-1.24%)
Nov 21, 2025, 11:59 AM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 30.28 billion as of November 20, 2025. Its market cap has decreased by -13.46% in one year.
Market Cap
30.28B
Enterprise Value
154.72B
Revenue
285.94B
Ranking
n/a
PE Ratio
9.87
Stock Price
4.76
Market Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 30.28B, a decrease of -45.55%. That is a compound annual growth rate of -6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 30.28B | -15.44% |
| Dec 31, 2024 | 35.81B | 11.11% |
| Dec 29, 2023 | 32.23B | -18.83% |
| Dec 30, 2022 | 39.71B | 78.03% |
| Dec 31, 2021 | 22.30B | -10.80% |
| Dec 31, 2020 | 25.00B | -44.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 300.83B |
| Hansoh Pharmaceutical Group Company | 235.98B |
| JD Health International | 217.70B |
| Innovent Biologics | 158.00B |
| WuXi Biologics | 132.11B |
| Sino Biopharmaceutical | 125.67B |
| Akeso | 104.18B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.51B |